Catalyst Event
Tempus AI Inc (TEM) · Other
From Akros U.S. AI Software TOP4 Plus Index (AUAIS4P)
5/21/2026, 12:00:00 AM
Tempus announced the clinical launch of the ArteraAI Prostate Test on May 21, 2026; estimated 5-10% price impact as the first external algorithm integration expands platform utility.
Korean Translation
Tempus는 2026년 5월 21일 ArteraAI 전립선 테스트의 임상적 출시를 발표함. 최초의 외부 알고리즘 통합으로 플랫폼 활용도가 확대되어 5-10%의 가격 영향이 예상됨.
Related Recent Events
AppLovin Corporation (APP) · Earnings Release
AppLovin's Q2 2026 earnings release, which typically has low immediate price impact upon date announcement, is scheduled.
8/5/2026, 12:00:00 AM
Oracle Corp (ORCL) · Earnings Release
Oracle is scheduled to release its Q4 fiscal year 2026 financial results on June 16, 2026. The company has forecasted total revenue growth of 19-21% and non-GAAP EPS between $1.96 and $2.00, scheduled.
6/16/2026, 12:00:00 AM
SALESFORCE INC (CRM) · Earnings Release
Salesforce is scheduled to release its first quarter fiscal 2027 financial results after the market closes on May 27, 2026, scheduled.
5/27/2026, 12:00:00 AM
Snowflake Inc (SNOW) · Earnings Release
Snowflake is scheduled to release its Q1 fiscal 2027 results for the period ending April 30, 2026, on May 27, 2026; a 10% price impact is estimated based on historical volatility scheduled
5/27/2026, 12:00:00 AM
Innodata Inc (INOD) · Other
CEO Jack Abuhoff reported selling 152,800 shares on May 19-20, 2026, following option exercises for long-term financial planning; insider sales for diversification typically result in a minor price impact of 1% or more.
5/20/2026, 12:00:00 AM
SALESFORCE INC (CRM) · Other
Bank of America analysts forecast Salesforce's performance with an 'Underperform' rating and a $160 price target on May 18, 2026, citing concerns about an AI-driven structural reset and limited monetization pathways, forecasted.
5/18/2026, 12:00:00 AM